MedCentralRevised Criteria for Diagnosing Vascular Cognitive Impairment and Dementia

New diagnostic criteria reveal vascular cognitive impairment and dementia affects far more patients than previously recognized—misdiagnosed as Alzheimer’s in up to 80% of cases despite being second leading cause of dementia. Experts warn most diagnoses come from primary care or general neurologists unfamiliar with rapidly evolving guidelines, leaving patients vulnerable to ineffective or dangerous treatments.

🎯 CLINICAL CONSIDERATIONS

• Cognitive assessment focuses on six domains (attention/processing speed, executive function, learning/memory, language, perceptual-motor, social cognition) and requires decline in just one domain plus neuroimaging confirmation for diagnosis.
• MRI/CT evidence required showing intracerebral hemorrhage, infarcts, or lacunes with white matter hyperintensities. A clinical stroke history is helpful but neither necessary nor sufficient for diagnosis.
• Small vessel disease presentations masquerade as depression, gait problems, or falls rather than cognitive complaints. Patients often develop compensatory behaviors that mask mild impairment.
• Biomarker-positive AD becomes default diagnosis even when vascular pathology drives clinical picture; a misdiagnosis prevents aggressive vascular risk management that could stabilize progression.

💊 PRACTICE APPLICATIONS

• Screen patients with vascular risk factors using MoCA or MMSE before attributing cognitive changes to normal aging
• Order brain MRI over CT when feasible to detect cerebral microbleeds and white matter disease missed on CT scans
• Assess amyloid PET or CSF biomarkers before prescribing anti-amyloid infusions—patients with vascular damage face increased bleeding risk from these medications
• Target hypertension, cholesterol, blood sugar, sleep apnea, and smoking aggressively in vaMCI patients—lifestyle modification can maintain stability for years

More on Alzheimer’s/Dementia